Concepedia

Publication | Open Access

Clinical Trial with Sodium <sup>99m</sup>Tc-Pertechnetate Produced by a Medium-Energy Cyclotron: Biodistribution and Safety Assessment in Patients with Abnormal Thyroid Function

15

Citations

16

References

2016

Year

Abstract

A single-site prospective open-label clinical study with cyclotron-produced sodium <sup>99m</sup>Tc-pertechnetate (<sup>99m</sup>Tc-NaTcO<sub>4</sub>) was performed in patients with indications for a thyroid scan to demonstrate the clinical safety and diagnostic efficacy of the drug and to confirm its equivalence with conventional <sup>99m</sup>Tc-NaTcO<sub>4</sub> eluted from a generator. <b>Methods:</b><sup>99m</sup>Tc-NaTcO<sub>4</sub> was produced from enriched <sup>100</sup>Mo (99.815%) with a cyclotron (24 MeV; 2 h of irradiation) or supplied by a commercial manufacturer (bulk vial eluted from a generator). Eleven patients received 325 ± 29 (mean ± SD) MBq of the cyclotron-produced <sup>99m</sup>Tc-NaTcO<sub>4</sub>, whereas the age- and sex-matched controls received a comparable amount of the generator-derived tracer. Whole-body and thyroid planar images were obtained for each participant. In addition to the standard-energy window (140.5 keV ± 7.5%), data were acquired in lower-energy (117 keV ± 10%) and higher-energy (170 keV ± 10%) windows. Vital signs and hematologic and biochemical parameters were monitored before and after tracer administration. <b>Results:</b> Cyclotron-produced <sup>99m</sup>Tc-NaTcO<sub>4</sub> showed organ and whole-body distributions identical to those of conventional <sup>99m</sup>Tc-NaTcO<sub>4</sub> and was well tolerated. All images led to a clear final diagnosis. The fact that the number of counts in the higher-energy window was significantly higher for cyclotron-produced <sup>99m</sup>Tc-NaTcO<sub>4</sub> did not influence image quality in the standard-energy window. Image definition in the standard-energy window with cyclotron-produced <sup>99m</sup>Tc was equivalent to that with generator-eluted <sup>99m</sup>Tc and had no particular features allowing discrimination between the <sup>99m</sup>Tc production methods. <b>Conclusion:</b> The systemic distribution, clinical safety, and imaging efficacy of cyclotron-produced <sup>99m</sup>Tc-NaTcO<sub>4</sub> in humans provide supporting evidence for the use of this tracer as an equivalent for generator-eluted <sup>99m</sup>Tc-NaTcO<sub>4</sub> in routine clinical practice.

References

YearCitations

Page 1